Saturday, February 04, 2006


Hep C - Daily Planner: Monday


Daily Planner: Monday
Chico Enterprise-Record - Jan 23 12:09 AM
HAS BEANS: 8 p.m., 501 Main St., Chico. Mikeless open mike; spoken word performances. Ongoing. BLOOD DRIVE: Donor hours 8 a.m.-1 p.m. Saturday; 8 a.m.-3 p.m. Monday and Wednesday; 11 a.m.-6 p.m. Tuesday and Thursday; 7 a.m.-2 p.m. Friday. BloodSource, 555 Rio Lindo Ave., Chico. 893-5433. Weekly.Save to My Web

Girl, 7, finds mother dead of overdose
icWales - Jan 27 9:54 AM
THE body of a mother who died of a heroin overdose was discovered by her seven-year-old daughter when she picked a lock with a knife. An inquest heard that Melanie Howells told her daughter Ayla she was going for a bath after the pair watched Coronation Street on the night she died.Save to My Web

Inovio inks deal to develop hep C vaccine
San Diego Daily Transcript via Yahoo! News - Jan 17 8:54 AM
Inovio Biomedical Corp. (AMEX: INO, News) announced Tuesday that it has signed an agreement with Swedish firm Tripep AB to develop a therapeutic vaccine for hepatitis C virus (HCV).Save to My Web

Speed the Plough
Motley Fool via Yahoo! Finance - Jan 30 7:12 AM
Schering-Plough is still in a precarious position, but it's likely to have above-average growth.Save to My Web

Friday, February 03, 2006


Hep C - RenalWEB Topic - Hepatitis


RenalWEB Topic - Hepatitis
Viral Hepatitis C National Hepatitis C Prevention Strategy Viral Hepatitis D Viral Hepatitis E Top 11 Most Frequently Asked Questions About Viral

HEPATITIS C INFO CENTER - With Daily Hepatitis C Updates
Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program PR Newswire via Charlotte Observer Jan 18 2006 6:51PM GMT Inovio and Tripep to develop hepatitis C vaccine

Hepatitis C in the Liver Allograft Recipient
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation 1998;65(1):82-86 . Please mail comments

Hepatitis, Viral
Management of viral hepatitis C. J Gastroenterol Hepatol . 2002;17 Suppl: S146-S154. Liaw YF, Leung NW, Chang TT, et al. Effects of extended lamivudine therapy in Asian patients with chronic

Hepatitis C: FAQ | CDC Viral Hepatitis
Frequently Asked Questions About Hepatitis C Diagnosis and testing What is hepatitis C? Is there a vaccine for the prevention of HCV infection? What

Hepatitis C: Index | CDC Viral Hepatitis
A thematic index of methamphetamine-related journal articles. Viral hepatitis C Prevention for Injection Drug Users (external link*) What Every

Hep C - Hepatitis c


Hepatitis c
... 50 percent of persons with early hepatitis C infections and in almost all with chronic hepatitis C infections ... to treat some people with chronic hepatitis C. This can improve liver ...

NIDA - NIDA Community Drug Alert Bulletin - Hepatitis
... to prevent HCV infection, and treatments for chronic hepatitis C have been effective only in some ... is approved for treatment of chronic hepatitis C. Researchers are working to ...

Management of Chronic Hepatitis C: Summary of Evidence Report/Technology Assessment, No. 60
Evidence Report/Technology Assessment: Number 60. Management of Chronic Hepatitis C. Summary ... acute hepatitis C develop a chronic infection. Chronic hepatitis C is often asymptomatic but may lead to ... year survival of those with chronic hepatitis C is approximately 50 percent ...

Hepatitis C
Hepatitis C. By Howard J. Worman, M. D. The Hepatitis C Virus (HCV) HCV was discovered in 1989 by investigators at Chiron, Inc. ... problem in discussing prognosis in patients with chronic hepatitis C is that it is difficult to predict ... strongly suggests the diagnosis of chronic hepatitis C. The absence of anti ...

Hepatitis C
Hepatitis C. Hepatitis C (formerly called non-A, non-B hepatitis) is a liver disease caused by a recently identified bloodborne virus. ... FDA has approved a drug called recombinant alpha interferon for treating people with chronic hepatitis C ... seldom occurs from people with chronic hepatitis C disease to their steady ...

Viral Hepatitis C
... Almost all chronic hepatitis C infections do not improve spontaneously ...

Thursday, February 02, 2006


Hep C - Weight-based Treatment of HCV


Weight-based Treatment of HCV
Weight-based dosing has always made sense to us. We don't really understand why Roche has not changed their dosing to weight-based. Although the difference is subtle, it is certainly significant according to this study. You must also note, though, that...

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

Wednesday, February 01, 2006


Hep C - Lipid Sciences, Inc. Receives Conditional Approval From the FDA of Investigational Device Exemption (IDE) Application


Lipid Sciences, Inc. Receives Conditional Approval From the FDA of Investigational Device Exemption (IDE) Application
[Press Release] Market Wire via Yahoo! Finance - Jan 31 5:30 AM
Lipid Sciences, Inc. today reported that it had received conditional approval for the Company's Investigational Device Exemption application from the Center for Devices and Radiological Health of the Food and Drug Administration to begin a human clinical trial of the Company's Plasma Delipidation System-2.Save to My Web

Migenix: infectious ambitions in hepatitis
Pharmaceutical Business Review - Jan 25 6:07 PM
Migenix has confirmed plans to initiate a viral kinetics study with celgosivir in hepatitis C.Save to My Web

Transgene Receives Grant for Hepatitis C Vaccine
RedNova - Jan 26 9:14 PM
France-based biopharmaceutical company Transgene has been awarded an E1.3 million for the development of its therapeutic vaccine candidate against hepatitis C chronic infection.Save to My Web

He's a fighter
News Gleaner - Feb 01 12:09 PM
Six years ago, Wissinoming resident John Waddell gave hope to Philadelphia firefighters who had just learned they were infected with the Hepatitis C virus.Save to My Web

Nabi Biopharmaceuticals Announces U.S. Fast Track Designation for Civacir to Prevent Hepatitis C Re-infection in Liver
[Press Release] PR Newswire via Yahoo! Finance - Feb 01 4:15 PM
Nabi Biopharmaceuticals today announced important regulatory and clinical advancements for its product candidate Civacir [Hepatitis C Immune Globulin ], an antibody for preventing Hepatitis C virus re-infection in liver transplants.Save to My Web

Hep C - USDA Funded Projects


USDA Funded Projects
diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. E) Determine the effects of sample handling on laboratory tests for bovine tuberculosis. The

World J Gastroenterol
does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. World J Gastroenterol 8(5):868-871 Mutational

ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195. Bassett SE, Thomas D, Brasky, KM, Lanford RE. 1999. Viral persistence antibody to E1 and E2, and hypervariable region 1

Nurses and Hepatitis C
Coinfection HIV & Viral Heaptitis: a guide December 2003 Third Edition Produced in Association with the Australian Liver Association, Gastroenterological Society of Australia, Australian Hepatitis

Lamivudine does not increase the efficacy of interferon in the
does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B World J Gastroenterol 2002 Oct;8(5):868-71Related Articles, Links Lamivudine does not increase

Viral Hepatitis
viral heaptitis viral heptaitis viral hepaittis viral hepattiis viral hepatiits viral hepatitsi viral hepatitsi hamlakeauctions.com Sunday 15th of January 2006 04:14:23 PM msnbot/1.0 (+http://search.msn.com

Tuesday, January 31, 2006


Hep C - Non-Hodgkin's lymphoma risk increased with prolonged high HIV ...


Non-Hodgkin's lymphoma risk increased with prolonged high HIV ...
Aidsmap, UK - Jan 10, 2006... In addition, their data suggest that a history of hepatitis C infection may be protective against NHL, and they conclude that this warrants further ...

My dad was dying and we never knew
Norfolk Eastern Daily Press, UK - Jan 26, 2006... This include raising awareness of groups that may have been at past risk of hepatitis C infection including recipients of blood transfusion before donor ...

HAART reduces liver-related death risk, but hepatitis C infection ...
Aidsmap, UK - Jan 18, 2006Highly active antiretroviral therapy (HAART) reduces the risk of liver-related death by 68%, although infection with both HIV and hepatitis C virus (HCV ...

ICAAC: HCV only factor associated with liver problems in patients ...
Aidsmap, UK - Jan 8, 2006... Frequent alcohol use was associated with a threefold increase in the risk of hepatotoxicity, independent of hepatitis C infection (risk ratio 3.2, p<0.01). ...

Hep C - AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus ...


AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus ...
PharmaLive.com (press release), PA - Jan 13, 2006... how effective this approach can be, but it is also encouraging for our work in treating additional viral diseases, such as chronic hepatitis C infection, which ...

(PRN) - CYIOS Corporation Announces Record Quarterly and Annual ...
Bolsamania.com, Spain - Jan 10, 2006... Awards ... [+. PRN) - Romark to Develop Alinia(R) (nitazoxanide) as New Treatment for Chronic Hepatitis C ... [+. PRN) - Spartan ...

Romark Laboratories to Develop Alinia as New Treatment for Chronic ...
EndoNurse, AZ - Jan 10, 2006TAMPA, Fla. -- Romark Laboratories announced that it is initiating US clinical development of Alinia (nitazoxanide) tablets for treating chronic hepatitis C. ...

Researchers develop new vaccine candidate against Hepatitis C
Laboratory Products News, Canada - 9 hours ago... For those who develop chronic hepatitis, the immune system cannot clear the infection. "In patients with chronic hepatitis C, there is evidence that the ...

FDA Approvals: RPS Adeno Detector, Elecsys NT-proBNP Test, TBA ...
Medscape (subscription) - Jan 6, 2006... hepatitis, liver sclerosis, and liver cancer; monitoring of therapeutic efficacy in patients receiving interferon for chronic hepatitis C virus infection, and ...

Hep C - HCV Overview : ViraCor Laboratories


HCV Overview : ViraCor Laboratories
HCV is a member of the Flavivirus family. 1 It is a single-stranded, positive-sense RNA virus which is spherical and lipid-enveloped. 1 HCV was discovered in the late 1980s, and is considered to be

Login
Please enter your account name and password. To register for an Account Name and Password please click here . Account Name: Password: Forgot your password? Change my password

HIV and HCV - Liver Health Information - The American Liver Foundation
HIV/HCV co-infection? Co-infection is a medical term meaning that you have two or more infections in your body at the same time. If you have HIV/HCV co-infection, then you have both HIV and HCV. These

HCV RNA Quantification - Hepatitis C News Articles
HCV RNA / TMA assay (Qualitative) RT-PCR / bDNA (Quantitative) Detection of HCV Core Antigen Is Quick, Easy Alternative to HIV RNA and Could Be Used to Predict

Monday, January 30, 2006


Hep C - Hepatitis C Patients Taxing Medical System


Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Health Tip: Nail Salon Safety
Title: Health Tip: Nail Salon SafetyCategory: Health NewsCreated: 4/12/2005 1:59:00 AMLast Editorial Review: 4/12/2005 1:58:31 AM

Sunday, January 29, 2006


Hep C - Hepatitis C


Hepatitis C
Hepatitis C. By Howard J. Worman, M. D. The Hepatitis C Virus (HCV) HCV was discovered in 1989 by investigators at Chiron, Inc.

Hepatitis C
Hepatitis C - origins, spread and treatment. ... Prevalence, impact and risk factors of hepatitis C infection; J Egypt Public Health Assoc ... 2): 117-122; 1996 Feb. 10. Hepatitis C Infection and clonal B-Cell expansion; Sansonno D et ...

Hepatitis C
... and antiviral response of patients with hepatitis C infection on methadone maintenance therapy receiving Pegasys ...

WebMD: Hepatitis C Topic Overview
... What are the symptoms of hepatitis C infection? In cases of acute infection, young children usually have no ... What are the symptoms of hepatitis C infection? Who is affected by ...

Conference Report - Hepatitis C Infection
Michael P. Manns, MD, and Heiner Wedemeyer, MD, discuss the latest issues in the treatment of chronic hepatitis C, with a view toward future therapies. ... Report. Hepatitis C Infection: Optimizing Treatment, Patient Management, and Basic Aspects ... Introduction -- Therapy of Chronic Hepatitis C Infection. Treatment of chronic hepatitis C ...